Alk-Abello AS (AKBLF)
22.05
0.00 (0.00%)
USD |
OTCM |
Nov 21, 16:00
Alk-Abello Profit Margin (Quarterly): 16.15% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 16.15% |
June 30, 2024 | 14.63% |
March 31, 2024 | 17.17% |
December 31, 2023 | 10.41% |
September 30, 2023 | 10.54% |
June 30, 2023 | 5.82% |
March 31, 2023 | 13.21% |
December 31, 2022 | 6.24% |
September 30, 2022 | 4.90% |
June 30, 2022 | 4.02% |
March 31, 2022 | 14.11% |
December 31, 2021 | 6.92% |
September 30, 2021 | 3.99% |
June 30, 2021 | -2.42% |
March 31, 2021 | 12.44% |
December 31, 2020 | -3.13% |
September 30, 2020 | -2.59% |
June 30, 2020 | -1.30% |
March 31, 2020 | 9.00% |
December 31, 2019 | -1.47% |
September 30, 2019 | -1.89% |
June 30, 2019 | -8.66% |
March 31, 2019 | 5.19% |
December 31, 2018 | -18.55% |
September 30, 2018 | -4.69% |
Date | Value |
---|---|
June 30, 2018 | -2.38% |
March 31, 2018 | 3.19% |
December 31, 2017 | -20.84% |
September 30, 2017 | -4.69% |
June 30, 2017 | -0.14% |
March 31, 2017 | 0.25% |
December 31, 2016 | 4.77% |
September 30, 2016 | 6.19% |
June 30, 2016 | 9.31% |
March 31, 2016 | 14.50% |
December 31, 2015 | 20.23% |
September 30, 2015 | 9.30% |
June 30, 2015 | 9.56% |
March 31, 2015 | 13.69% |
December 31, 2014 | 2.61% |
September 30, 2014 | 4.98% |
June 30, 2014 | 5.04% |
March 31, 2014 | 15.79% |
December 31, 2013 | 6.75% |
September 30, 2013 | 1.77% |
June 30, 2013 | -5.64% |
March 31, 2013 | 6.89% |
December 31, 2012 | -2.44% |
September 30, 2012 | 9.21% |
June 30, 2012 | 24.85% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.13%
Minimum
Dec 2020
17.17%
Maximum
Mar 2024
6.93%
Average
6.58%
Median
Profit Margin (Quarterly) Benchmarks
Genmab AS | 22.85% |
Ascendis Pharma AS | -171.5% |
Galecto Inc | -- |
Evaxion Biotech AS | -64.14% |
IO Biotech Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 16.70% |
Return on Assets | 11.44% |
Return on Invested Capital | 15.72% |
Gross Profit Margin (Quarterly) | 64.13% |
Operating Margin (Quarterly) | 23.31% |
Return on Net Operating Assets | 13.21% |